GITNUX MARKETDATA REPORT 2024

Pramipexole Effectiveness Duration Statistics

Pramipexole's effectiveness typically lasts for around 5 to 7 years before the onset of motor complications in the treatment of Parkinson's disease.

With sources from: accessdata.fda.gov, my.clevelandclinic.org, aafp.org, pubmed.ncbi.nlm.nih.gov and many more

Statistic 1

Pramipexole significantly reduces the off time in Parkinson's patients by a mean value of 1.7 hours per day.

Statistic 2

After 12 weeks treatment, about 64% of Pramipexole patients with Parkinson's disease showed >or= 20% improvement.

Statistic 3

Pramipexole begins to work 2 to 3 weeks after starting the medicine.

Statistic 4

Around 77% of patients being treated for restless legs syndrome with pramipexole had both drastic symptom reduction and sleep improvement.

Statistic 5

Over 84% of patients on pramipexole medication showed improvement in unified Parkinson's disease rating scale (UPDRS).

Statistic 6

Most common side effects occurred in 50% of patients taking pramipexole.

Statistic 7

Reduction of the dose of levodopa was possible in 84% of patients taking pramipexole.

Statistic 8

In a study, pramipexole demonstrated at 26 weeks, a reduction by 11.0 points for immediate release and by 9.1 points for extended release on the UPDRS scale.

Sources Icon Sources

In this post, we explore the effectiveness and duration of pramipexole in the treatment of Parkinson’s disease and restless legs syndrome. With statistics indicating significant reductions in off time, improvements in symptom severity, and potential benefits on sleep quality, the impact of pramipexole on patient outcomes is worth closer examination. Let’s delve into the data to understand the implications of pramipexole treatment in these neurological conditions.

Statistic 1

"Pramipexole significantly reduces the off time in Parkinson's patients by a mean value of 1.7 hours per day."

Sources Icon

Statistic 2

"After 12 weeks treatment, about 64% of Pramipexole patients with Parkinson's disease showed >or= 20% improvement."

Sources Icon

Statistic 3

"Pramipexole begins to work 2 to 3 weeks after starting the medicine."

Sources Icon

Statistic 4

"Around 77% of patients being treated for restless legs syndrome with pramipexole had both drastic symptom reduction and sleep improvement."

Sources Icon

Statistic 5

"Over 84% of patients on pramipexole medication showed improvement in unified Parkinson's disease rating scale (UPDRS)."

Sources Icon

Statistic 6

"Most common side effects occurred in 50% of patients taking pramipexole."

Sources Icon

Statistic 7

"Reduction of the dose of levodopa was possible in 84% of patients taking pramipexole."

Sources Icon

Statistic 8

"In a study, pramipexole demonstrated at 26 weeks, a reduction by 11.0 points for immediate release and by 9.1 points for extended release on the UPDRS scale."

Sources Icon

Interpretation

Overall, the statistics presented highlight the effectiveness of pramipexole in improving symptoms and quality of life for patients with Parkinson's disease and restless legs syndrome. Pramipexole demonstrates a significant reduction in off time, improvement in motor symptoms, and potential for dose reduction of other medications. The medication shows promise in providing relief within a few weeks of starting treatment and is associated with manageable side effects. These findings support the continued exploration and utilization of pramipexole as a valuable treatment option for individuals living with these neurological disorders.

Can You Trust Our Report?

The statistics are checked by us and then entered into the database. Our market data reports have been linked to by some of the largest publishers and companies on the Internet.

Learn more about our process here.

Submit Your Own Statistic Data

Would you like to submit your own researched statistics on this topic? You are welcome to use the form below and submit your suggestion to us. We will check the source and approve it if necessary.

... Before You Leave, Catch This! 🔥

Your next business insight is just a subscription away. Our newsletter The Week in Data delivers the freshest statistics and trends directly to you. Stay informed, stay ahead—subscribe now.

Sign up for our newsletter and become the navigator of tomorrow's trends. Equip your strategy with unparalleled insights!